ATRIX LABORATORIES INC
10-Q, EX-27, 2000-07-28
PHARMACEUTICAL PREPARATIONS
Previous: ATRIX LABORATORIES INC, 10-Q, 2000-07-28
Next: BLUE CHIP VALUE FUND INC, N-30D, 2000-07-28



<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                         666,307
<SECURITIES>                                27,564,061
<RECEIVABLES>                                2,794,464
<ALLOWANCES>                                    50,305
<INVENTORY>                                  2,359,167
<CURRENT-ASSETS>                            34,819,056
<PP&E>                                      10,974,030
<DEPRECIATION>                               4,120,882
<TOTAL-ASSETS>                              46,804,328
<CURRENT-LIABILITIES>                        2,195,133
<BONDS>                                     36,690,000
                                0
                                          0
<COMMON>                                        11,483
<OTHER-SE>                                   7,907,712
<TOTAL-LIABILITY-AND-EQUITY>                46,804,328
<SALES>                                      2,820,652
<TOTAL-REVENUES>                             3,685,802
<CGS>                                        1,123,084
<TOTAL-COSTS>                               10,665,036
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                50,305
<INTEREST-EXPENSE>                           1,296,460
<INCOME-PRETAX>                            (7,309,534)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (7,309,534)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (7,309,534)
<EPS-BASIC>                                     (0.64)
<EPS-DILUTED>                                   (0.64)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission